PIRG Comments to NIH relating to patents and prescription drugs

How should publicly-funded science be licensed and patented for the public good?

PIRG submitted comments to the National Institutes of Health (NIH) workshop, Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer, held on July 31, 2023.

Learn more.

Topics
Authors

Patricia Kelmar

Senior Director, Health Care Campaigns, U.S. PIRG Education Fund

Patricia directs the health care campaign work for U.S. PIRG and provides support to our state offices for state-based health initiatives. Her prior roles include senior policy advisor at NJ Health Care Quality Institute, associate state director at AARP New Jersey and consumer advocate at NJPIRG. She was appointed to the Ground Ambulance and Patient Billing Advisory Committee in 2022 and works with patient advocates across the U.S. Patricia enjoys walking along the Potomac River and sharing her love of books with friends and family around the world.

Find Out More